PFAS is big business and all over the news in the US. A multi Billion market opportunity. BioLargo has the most effective and cost-efficient PFAS treatment solution and first commercial Pilot Projects are about to start... Toxic ‘Forever Chemicals' Are Found Everywhere. What You Need to Know About PFAS Published 4 hours ago https://www.nbclosangeles.com/news/...ere-what-you-need-to-know-about-pfas/2653672/
The Mineral extraction project reminds me a bit of mining projects, the only difference is that you cannot mine without BioLargo’s technology and you will have a liability to get rid of the waste properly instead. In my opinion the Net Present Value of the extraction project of valuable mineral resources is likely multiples of the current market cap of BioLargo. The project is expected to generate over $1B in revenues. July 27, 2021 https://stockdaymedia.com/biolargo-...ng-contracts-with-the-stock-day-podcast-blgo/ “In our shareholder’s meeting just a few weeks ago, we talked about a very large magnesium project where we’ve taken a waste stream from a mining operation and have shown our client [that we can] convert that to well over a billion in revenue,” said Calvert. “It’s heading into serious negotiations and we’re hoping to bring that to closure in the near future,” he added. “We invented the technology that makes it work.”
Thanks for vid. I've been hearing about per-fluorinated and poly-fluorinated alkyl substances (PFAS) relative to urban farming and the potential dangers food from urban farms may impose on the public, as some plants are hyper-accumulators of toxic substances like heavy metals and, I guess, PFAS. My take-aways from the vid: The EPA has no regulations for PFAS so the States have to come up with their own regulations There are no enforceable Safe Drinking Water Act standards The EPA has no lab methods for testing for PFAS except for drinking water but that is expensive and challenging Clean-up options are limited (this is presumably where BLGO comes in) For now States are focused on identifying sources and areas of contamination and how to remove and clean-up We know that the EPA's budget was slashed by the last administration, so that may explain why all the commotion on PFAS, which is everywhere, including in our own bodies...so that it will be politically acceptable to increase the EPA's budget...so as usual there is likely a hidden agenda. The vid made it sound like there are all these states concerned about finding and cleaning up PFAS sites. I'm not convinced that is the case, but I'd need to do more research. I do know that military bases have been clearly identified. So I wonder if BLGO has or is working on a contract with the DOD. Which leads to another question, does BLGO have the political connections necessary to be awarded a federal contract? Oh wait, that's not supposed to be the way contracts are awarded...yeah right.
Thanks for your comments, good points. BioLargo already has business relations with the US Army... BioLargo's Engineering Subsidiary on a Hot Streak with New Contract Awards June 29, 2021 https://irdirect.net/prviewer/release_only/id/4764114 These new contract wins are for work with 1) a resin manufacturing facility, 2) a dairy farm, 3) a new project at Picatinny Arsenal, one of the company's long-time customers, 4) a potato processing plant, and 5) a US Air Force base, adding to the other seven bases already served by the company. Together, the new contracts are worth more than $1.2 million in revenue, most of which will be earned over the next six months. https://last10k.com/sec-filings/blgo/0001437749-21-007650.htm#link_fullReport "Broadly speaking, there are three main markets for PFAS water treatment in the U.S., each of which we intend to address in the coming years. The first is municipal water treatment – that is water which needs treatment for PFAS before it can be distributed to the public or water that must be treated from a wastewater treatment plant. Southern California, Michigan and Wisconsin may be hotbeds for this market, as the states have adopted stringent regulations on PFAS limits in drinking water and wastewater, and significant initiatives have begun to implement systems to address the problem. The second market is military bases, where the use of PFAS-containing fire-fighting foam has contaminated the soil and groundwater. These sites are numerous and have significant groundwater and soil contamination problems which regulators are likely to require remediation for in the coming years. The third market is treatment for water intake or outfalls of industrial facilities that use PFAS compounds in manufacturing and other industrial processes. Our first pilot projects are in municipal water treatment. As our engineers are already providing environmental engineering services on U.S. Airforce bases, we believe that work may lead to sales in that arena."
Biolargo (BLGO) water cleaning technology could bring clean water for all August 3, 2021 https://woodlandreport.com/2021/08/...g-technology-could-bring-clean-water-for-all/ The Bull thesis Commercialization is in full swing; revenues growing and debt paid off and at least one of those above mentioned endeavors will become a big success. More than one and we will do amazingly well – but it is actually looking good that a lot of not all will become a success = a potential Clean Tech Jackpot. The Bear thesis BioLargo has been a company operating for more than a decade and they spent way too long in R&D without being able to significantly monetize their developments. As a “logical” consequence they will never be able to monetize anything and not a single one of the above will succeed.
'Forever chemicals' detected in water systems of nearly 2,800 US cities | ABC News ABC News, August 11th, 2021
The event features water industry experts and thought leaders, including BioLargo's Tonya Chandler. https://events.r20.constantcontact.com/register/eventReg?oeidk=a07eido3a3bf1c18f98&oseq=&c=&ch=
BioLargo Launches PFAS Testing and Treatment System Selection Program September 02, 2021 https://irdirect.net/prviewer/release_only/id/4849158 Randall Moore, President of BioLargo's engineering division said, "With the launch of this new program, our engineers will be able to better serve municipalities that are struggling with having to close water wells due to PFAS contamination. Our AEC system reduces treatment costs because it generates only a fraction of the PFAS-laden waste compared to other treatment technologies like carbon filtration or ion exchange. No two water sources have the same underlying chemistry, and there are over 4,500 different PFAS compounds that can contaminate water. Thus, it is crucial to optimize treatment processes for each situation."
BioLargo presentation at H.C. Wainwright 23rd Annual Global Investment Conference on September 13, 2021 https://journey.ct.events/view/8fc14545-db68-4397-90e6-45267377c156
CEI is aleady a hot stock and soaring... CEI and BLGO may benefit tremendous returns in 2022 September 13, 2021 https://woodlandreport.com/2021/09/cei-and-blgo-may-benefit-tremendous-returns-in-2022/
BioLargo's Groundbreaking Technology to Eliminate the Presence of Forever Chemicals in Drinking Water Mark Gilman , Benzinga Staff Writer September 22, 2021 https://www.benzinga.com/general/bi...-presence-of-forever-chemicals-in-drinking-wa ... Meanwhile, BioLargo has recently announced two new potential clients (a municipality in Southern California and a federal government agency). They recently sent the company PFAS-contaminated water samples to be treated by its AEC water treatment system. BioLargo sees this as an essential first step in its multi-phased commercial approach, which includes off-site treatment of client-supplied water, an on-site pilot treatment system at the client’s location, and ultimately, full-scale operations. “By treating client water with our in-house AEC system, we can optimize it for the unique characteristics of the water from each source and confirm for the client that our system removes PFAS to the levels that meet their particular regulatory requirements,” said Randall Moore, President of BioLargo’s engineering subsidiary. BioLargo is now preparing to build commercial-sized units for pilot projects to be used across the United States. The company is also aggressively pursuing potential markets in communities needing groundwater remediation near industrial sites, military bases, and airports.
BioLargo @BioLargo 2h Garratt-Callahan equipment being readied for delivery, new consumer goods partnership, AOS sales channels, and more! Thursday, 30 September 2021 Letter to Stockholders: BioLargo Positions for Expansive Commercial Reach Through Strategic Partnerships https://biolargo.blogspot.com/2021/09/letter-to-stockholders-biolargo.html Garratt-Callahan Product Launch ... Over the next few weeks, we will be finishing manufacturing the first units for final operational testing to verify its functionality before its full launch in early 2022. Garratt-Callahan aims to deliver 25-35 units of this new product to its customers in the first year alone, with each unit selling in a range that we believe will be competitively priced in the $100,000-$500,000 range. Additional opportunities with Garratt-Callahan, such as product development, manufacturing, and the sale of other BioLargo products, are being discussed. ... PFAS Treatment Projects Our PFAS chemical water treatment device, the Aqueous Electrostatic Concentrator (AEC), is making progress towards a commercial launch that we expect to occur in the first half of 2022. https://www.biolargoengineering.com/biolargo-pfas-testing-program/) that we believe will help develop market exposure for the AEC in advance of its commercial launch. ... To access this market quickly and effectively, we are bringing on board experienced water industry sales representatives, and will partner with other water treatment equipment and service providers who will act as distributors and re-sellers for the AEC. We intend to secure those partnerships after the next phase of our commercial launch, the execution of initial commercial trials, is complete. New Consumer Product Partnership Over the past six months, we have developed a relationship with a company founded by highly accomplished industry executives from the consumer packaged goods industry who have executed successful launches of at least five blockbuster products, that intends to launch a new consumer product based on our patented BioLargo technology. Our partner, Ikigai Holdings, LLC, has completed preliminary testing, developed the brand, and is in the process of developing television commercials and other marketing materials. It intends to begin test marketing the first product in the coming weeks, and assuming that test marketing phase is successful, will launch the product with the goal to sell to the major retailers in the United States. Our agreements provide that we will be the manufacturer of the new product (or products), and they will finance and manage roll-out, distribution, and marketing. We are excited about the potential for this partnership to create significant new revenue channels for BioLargo, but of course, at this point, as confident we are in our new partners, our legal advisors remind us that we cannot predict the future or whether the new product(s) will ultimately find success in the marketplace. With that caveat in place, our partners tell us that the initial television launch will provide highly reliable data indicating the size of the consumer market opportunity. Based on these results, a go-to-market strategy will be determined, and production will be planned. Jane Pak, Co-Founder of Ikigai Holdings, offered us this quote: “Creating a mass-market brand begins with finding superior products with unbeatable claims. Our research validated that the current leading odor eliminating products are inferior to the CupriDyne formula and we’re thrilled to have the opportunity to disrupt the consumer odor elimination category with such a compelling offer.” ...
Thursday, 30 September 2021 Peer-reviewed paper explains unprecedented performance of BioLargo’s AOS water treatment technology http://biolargo.blogspot.com/2021/09/peer-reviewed-paper-explains.html Today BioLargo published an important peer-reviewed article confirming that its innovative water treatment technology, the Advanced Oxidation System (AOS), generates highly energetic iodine molecules. The article establishes the foundational scientific principles about why the AOS is a powerful, efficient, and novel water treatment technology. ... Dr. Richard Smith, President of BioLargo Water commented, “Our AOS technology is a technical leap forward in advanced water treatment. This study is integral in showing why the technology produces such high performance while consuming so little energy.”
possible multibagger for 2022... BioLargo's Third Quarterly Report for 2021 Details Progress of PFAS Technology Commercialization and Ongoing Partnerships November 16, 2021 https://irdirect.net/prviewer/release_only/id/4939360 Financial highlights from the 10-Q: Consolidated revenue for the three months ended September 30, 2021, was $712,000, a 7% increase compared to the prior year's period. Revenue generated by BioLargo's engineering division increased by 73% compared to last year's period, and 92% as compared with the second quarter of 2021. The company's net loss during the quarter was reduced to $1.3 million, down from $2.1 million in the same period of the prior year. The improvement in the company's net loss is due in large part to a significant reduction in interest expenses due to retired debt over the past year. Commercial, operational, and R&D highlights: First PFAS testing successful - testing of water provided by the company's first prospective PFAS treatment client, a large municipality in southern California, has confirmed that BioLargo's PFAS treatment technology can remove all PFAS compounds of regulatory interest to below State and Federal standards. Additional testing to optimize the AEC underway. Testing with our second prospective client's water is slated to begin next week. Garratt-Callahan prototype unit completed - as part of BioLargo's partnership with the water treatment company Garratt-Callahan, BioLargo has just finished building a full-scale prototype unit of their patented "minimal liquid discharge" system for testing on client-provided water. The technology is designed to reduce industrial wastewater discharge and fees associated with discharge. BioLargo engineers will be testing the system's performance soon, and management targets first sales in the early 2022. Engineers break revenue record - BioLargo's engineering group's quarter-over-quarter revenue grew by 92% in Q3, having completed over half the work for the $1.2 million worth of engineering projects announced in June of 2021, the remainder of which is expected to complete in the next six months. 3-year exclusive chemistry supply contract - BioLargo's subsidiary ONM Environmental secured an exclusive three-year CupriDyne Clean supply contract with a large municipality in Southern California. TV test marketing shows promising results - a quote from Ikigai Holdings President Jane Pak on the new pet odor product based on BioLargo's technology: "The Ikigai team is pleased to see the product get a positive response early in the market testing period. The next three weeks of media placement will be critical to predicting probability of volume and velocity, but in our first week of placement we are already seeing some very promising results." AOS pilot confirms performance - the pilot project in Montreal, Quebec, has confirmed that the AOS is highly effective at removing pharmaceutical micropollutants from municipal wastewater in a real-world setting, faster and using less electricity than major incumbent technologies, making it an attractive product for municipal wastewater treatment customers. A video about this pilot is available here: https://biolargo.blogspot.com/2021/09/biolargo-aos-water-treatment-technology.html Peer-reviewed paper confirms AOS breakthrough - a peer-reviewed scientific paper was published confirming that the AOS generates highly energetic iodine molecules, helping explain why the AOS is a powerful, efficient, and novel water treatment technology. The article, and a summary thereof, can be accessed here: https://biolargo.blogspot.com/2021/09/peer-reviewed-paper-explains.html
Strong buy, Garrat-Callahan thinks they can sell at least 30-40 units. The price of one unit is project based between $200 - $500 thousands. First sales expected early 2022. Multiple shots on gold... From today's Q3 conference call:
BioLargo at 'apex of opportunity' as it sees strong engineering division growth in 3Q 17.11.2021 BioLargo Inc CEO Dennis Calvert tells Proactive it saw a jump in consolidated revenue during its third quarter. The company generated $712,000 in revenue, a 7% year-over-year increase. Revenue for its engineering division increased by 73% year-over-year and 92% month-over-month. Its net loss during the quarter was reduced to $1.3 million, down from $2.1 million in the year-ago period.
Multiple shots on Gold. PFAS is obviously big business. This consumer product also sounds very promsing imo. "Another upcoming venture for BioLargo is a consumer odor control product being launched in collaboration with Ikigai Holdings, LLC, whose founders have successfully commercialized five revolutionary consumer products in the past. Together, the two companies intend to create a new mass-market brand based on BioLargo’s technology. BioLargo will serve as the manufacturer and technology licensor. The target is to get to $100 million within four years, Calvert says." California’s BioLargo discovers how to purge water of forever chemicals (PFAS) linked to cancer and birth defects https://calbizjournal.com/californi...cals-pfas-linked-to-cancer-and-birth-defects/ Letter to Stockholders September 30, 2021 https://feeds.issuerdirect.com/news-release.html?newsid=8816010632425541 New Consumer Product Partnership Over the past six months, we have developed a relationship with a company founded by highly accomplished industry executives from the consumer packaged goods industry who have executed successful launches of at least five blockbuster products, that intends to launch a new consumer product based on our patented BioLargo technology. Our partner, Ikigai Holdings, LLC, has completed preliminary testing, developed the brand, and is in the process of developing television commercials and other marketing materials. It intends to begin test marketing the first product in the coming weeks, and assuming that test marketing phase is successful, will launch the product with the goal to sell to the major retailers in the United States. Our agreements provide that we will be the manufacturer of the new product (or products), and they will finance and manage roll-out, distribution, and marketing. We are excited about the potential for this partnership to create significant new revenue channels for BioLargo, but of course, at this point, as confident we are in our new partners, our legal advisors remind us that we cannot predict the future or whether the new product(s) will ultimately find success in the marketplace. With that caveat in place, our partners tell us that the initial television launch will provide highly reliable data indicating the size of the consumer market opportunity. Based on these results, a go-to-market strategy will be determined, and production will be planned. Jane Pak, Co-Founder of Ikigai Holdings, offered us this quote: "Creating a mass-market brand begins with finding superior products with unbeatable claims. Our research validated that the current leading odor eliminating products are inferior to the CupriDyne formula and we're thrilled to have the opportunity to disrupt the consumer odor elimination category with such a compelling offer."
BLGO has several multi $Billion market opportunities and a ridiculous low market cap of $50 Million. The PFAS treatment solution alone is imo much more worth than the current market cap. My personal fav business opportunity is the Magnesium Carbonate production project. It reminds me a bit of mining projects, the only difference is that you cannot mine without BioLargo’s technology and you will have a liability to get rid of the waste properly instead. The Net Present Value of the extraction project of valuable mineral resources is likely multiples of the current market cap of BioLargo. The project is expected to generate over $1B in revenues. BLGO has multiple shots on Gold. Future looks very bright imo.
The pet odor product is the second significant revenue stream for 2022. Also Garrat-Callahan thinks they can sell at least 30-40 units of the new wastewater treatment product. The price of one unit is project based between $200 - $500 thousands. First sales expected early 2022. Plus PFAS is big business and all over the news in the US. BioLargo has the most effective and cost-efficient PFAS treatment solution. BioLargo Strategic Partnership with Ikigai to Launch New Consumer Product Direct to Consumer Test Marketing is Successful WESTMINSTER, CA / ACCESSWIRE / November 30, 2021 https://www.biolargo.com/company-news BioLargo, Inc. (OTCQB:BLGO), a developer of sustainable cleantech technologies and full-service environmental engineering company, announced that it had received a "go decision" from its strategic partner, Ikigai Holdings, LLC, following positive results from the test-marketing phase of a new pet odor control product based on BioLargo's proprietary technology, branded "POOPH". The "go decision" indicates Ikigai's intent to expand television advertising with the goal to launch the product into big-box retailers, and formalizes their exclusive license to the product. Ikigai Holdings, LLC is comprised of veteran consumer product executives with experience launching and growing multiple blockbuster consumer products. Ikigai developed the "POOPH" brand, created television commercials and other advertising content, and then conducted a television direct-response test marketing campaign to assess the probability that the product would be a commercial success. Jane Pak, Ikigai CEO, commented, "Early feedback from the test marketing of the POOPH product has been phenomenal. We have placed our initial purchase orders to support an expanded marketing campaign that will begin right after Christmas to gather additional data which will be instrumental in supporting accelerated consumer sales and establishing a strong transition from direct-to-consumer into retail. We are thrilled to see validation that POOPH can disrupt the highly established category of pet odor control products, and with these results, we are already thinking about more products based on BioLargo's technology." BioLargo CEO Dennis P. Calvert commented, "Ikigai will purchase the POOPH products from us, and in addition, we receive a royalty on sales. They will finance and manage product roll-out, distribution, and marketing. We are excited about the potential for this partnership to create significant new revenue for both partners. The team at Ikigai is amazing!"
BioLargo Signs Manufacturer’s Representative Agreement with ICS Group for its Innovative Water Treatment Technologies 12/01/2021 https://www.otcmarkets.com/stock/BL...vative-Water-Treatment-Technologies?id=333531 WESTMINSTER, CA / ACCESSWIRE / December 1, 2021 / BioLargo, Inc. (OTCQB:BLGO), a developer of sustainable cleantech technologies and full-service environmental engineering company, announced it has signed a manufacturer's representative agreement with the ICS Group, a premier manufacturer's representative company that has provided innovative wastewater, energy management, and renewable energy technology solutions to municipal and industrial clients, primarily in the Midwestern United States, since 2009. As this is the first manufacturer's representative for BioLargo's innovative water treatment technologies, this represents an important step toward building a commercial network for their sale and distribution. ICS Group has been tasked to sell BioLargo's two proprietary water treatment technologies, the Advanced Oxidation System (AOS) energy-efficient wastewater disinfection, micropollutant removal, and water reuse technology, and the Aqueous Electrostatic Concentrator (AEC) technology for affordable, low-waste treatment of PFAS-contaminated water, as well as other water and wastewater treatment equipment that BioLargo offers as an authorized reseller of other manufacturers. The ICS Group will also sell BioLargo's PFAS Testing Program service, which offers fast and affordable testing of clients' PFAS-contaminated water for the purposes of treatment system optimization, and CupriDyne Clean, the company's patented odor and volatile organic compound (VOC) control product. Paul Nygaard, President of ICS Group, said, "We specialize in innovative water and wastewater process technologies. We always strive to bring cutting edge technologies to the market that help our clients achieve challenging treatment objectives. BioLargo's unique technology platforms definitely bring that capability to our treatment solutions." "ICS Group has a reputation of outstanding customer service, making them the perfect choice to be our first manufacturer's representative for our technologies. They're also known for taking on new and innovative technologies that address unmet needs in the water treatment marketplace," said Tonya Chandler, BioLargo's Director of Strategic Marketing and Business Development. "We intend to add more sales representatives soon and hope they will be as great a fit as the ICS Group to our values."
